Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging.


Journal

Magnetic resonance in medicine
ISSN: 1522-2594
Titre abrégé: Magn Reson Med
Pays: United States
ID NLM: 8505245

Informations de publication

Date de publication:
05 2023
Historique:
revised: 16 12 2022
received: 01 11 2022
accepted: 19 12 2022
pubmed: 26 1 2023
medline: 3 3 2023
entrez: 25 1 2023
Statut: ppublish

Résumé

This article focuses on clinical applications of arterial spin labeling (ASL) and is part of a wider effort from the International Society for Magnetic Resonance in Medicine (ISMRM) Perfusion Study Group to update and expand on the recommendations provided in the 2015 ASL consensus paper. Although the 2015 consensus paper provided general guidelines for clinical applications of ASL MRI, there was a lack of guidance on disease-specific parameters. Since that time, the clinical availability and clinical demand for ASL MRI has increased. This position paper provides guidance on using ASL in specific clinical scenarios, including acute ischemic stroke and steno-occlusive disease, arteriovenous malformations and fistulas, brain tumors, neurodegenerative disease, seizures/epilepsy, and pediatric neuroradiology applications, focusing on disease-specific considerations for sequence optimization and interpretation. We present several neuroradiological applications in which ASL provides unique information essential for making the diagnosis. This guidance is intended for anyone interested in using ASL in a routine clinical setting (i.e., on a single-subject basis rather than in cohort studies) building on the previous ASL consensus review.

Identifiants

pubmed: 36695294
doi: 10.1002/mrm.29572
doi:

Substances chimiques

Spin Labels 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2024-2047

Subventions

Organisme : NCRR NIH HHS
ID : P41 RR002305
Pays : United States
Organisme : NIA NIH HHS
ID : K01 AG070318
Pays : United States

Informations de copyright

© 2023 The Authors. Magnetic Resonance in Medicine published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine.

Références

Haller S, Zaharchuk G, Thomas DL, Lovblad K-O, Barkhof F, Golay X. Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology. 2016;281:337-356.
Grade M, Hernandez Tamames JA, Pizzini FB, Achten E, Golay X, Smits M. A neuroradiologist's guide to arterial spin labeling MRI in clinical practice. Neuroradiology. 2015;57:1181-1202.
Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 2: hypoperfusion patterns. Am J Neuroradiol. 2008;29:1235-1241.
Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA. Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns. Am J Neuroradiol. 2008;29:1428-1435.
van der Plas MCE, Teeuwisse WM, Schmid S, Chappell M, van Osch MJP. High temporal resolution arterial spin labeling MRI with whole-brain coverage by combining time-encoding with look-locker and simultaneous multi-slice imaging. Magn Reson Med. 2019;81:3734-3744.
Sugimori H, Fujima N, Suzuki Y, Hamaguchi H, Sakata M, Kudo K. Evaluation of cerebral blood flow using multi-phase pseudo continuous arterial spin labeling at 3-tesla. Magn Reson Imaging. 2015;33:1338-1344.
Mutsaerts HJMM, Petr J, Groot P, et al. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 2020;219:117031.
Warnert EAH, Steketee RME, Vernooij MW, et al. Implementation and validation of ASL perfusion measurements for population imaging. Magn Reson Med. 2020;84:2048-2054.
Pinto J, Chappell MA, Okell TW, et al. Calibration of arterial spin labeling data-potential pitfalls in post-processing. Magn Reson Med. 2019;83:1222-1234. doi:10.1002/mrm.28000
Shirzadi Z, Stefanovic B, Chappell MA, et al. Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI. J Magn Reson Imaging. 2018;47:647-655.
Wu MM, Chan S-T, Mazumder D, et al. Improved accuracy of cerebral blood flow quantification in the presence of systemic physiology cross-talk using multi-layer Monte Carlo modeling. Neurophotonics. 2021;8:015001.
Wong EC, Cronin M, Wu W-C, Inglis B, Frank LR, Liu TT. Velocity-selective arterial spin labeling. Magn Reson Med. 2006;55:1334-1341.
Alsop DC, Detre JA, Golay X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the european consortium for ASL in dementia. Magn Reson Med. 2014;73:102-116. doi:10.1002/mrm.25197
Vidorreta M, Balteau E, Wang Z, et al. Evaluation of segmented 3D acquisition schemes for whole-brain high-resolution arterial spin labeling at 3 T. NMR Biomed. 2014;27:1387-1396.
Petr J, Mutsaerts HJMM, De Vita E, et al. Effects of systematic partial volume errors on the estimation of gray matter cerebral blood flow with arterial spin labeling MRI. Magma. 2018;31:725-734.
Ssali T, Anazodo UC, Narciso L, et al. Sensitivity of arterial spin labeling for characterization of longitudinal perfusion changes in frontotemporal dementia and related disorders. Neuroimage Clin. 2021;35:102853.
Zhao L, Vidorreta M, Soman S, Detre JA, Alsop DC. Improving the robustness of pseudo-continuous arterial spin labeling to off-resonance and pulsatile flow velocity. Magn Reson Med. 2017;78:1342-1351.
Clement P, Mutsaerts H, Vaclavu L, et al. Variability of physiological brain perfusion in healthy subjects - a systematic review of modifiers. Considerations for multi-center ASL studies. J Cereb Blood Flow Metab. 2017;In press;38:1418-1437. doi:10.1177/0271678X17702156
Haller S, Rodriguez C, Moser D, et al. Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: a BOLD and perfusion MRI study. Neuroscience. 2013;250:364-371.
Haller S, Montandon M-L, Rodriguez C, et al. Acute caffeine administration effect on brain activation patterns in mild cognitive impairment. J Alzheimers Dis. 2014;41:101-112.
Bokkers RPH, Bremmer JP, van Berckel BNM, et al. Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H(2) (15) O positron emission tomography in patients with symptomatic carotid artery occlusion. J Cereb Blood Flow Metab. 2010;30:222-229.
Jezzard P, Chappell MA, Okell TW. Arterial spin labeling for the measurement of cerebral perfusion and angiography. J Cereb Blood Flow Metab. 2018;38:603-626.
Wang DJ, Alger JR, Qiao JX, et al. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke-comparison with dynamic susceptibility contrast enhanced. NeuroImage Clin. 2013;3:1-7.
Van Der Thiel M, Rodriguez C, Giannakopoulos P, et al. Brain perfusion measurements using multidelay arterial spin-labeling are systematically biased by the number of delays. Am J Neuroradiol. 2018;39:1432-1438.
Heijtel DFR, Mutsaerts HJMM, Bakker E, et al. Accuracy and precision of pseudo-continuous arterial spin labeling perfusion during baseline and hypercapnia: a head-to-head comparison with 15O H2O positron emission tomography. Neuroimage. 2014;92:182-192.
Chen Z, Zhang X, Yuan C, Zhao X, van Osch MJP. Measuring the labeling efficiency of pseudocontinuous arterial spin labeling. Magn Reson Med. 2017;77:1841-1852.
Hales PW, Kirkham FJ, Clark CA. A general model to calculate the spin-lattice (T1) relaxation time of blood, accounting for haematocrit, oxygen saturation and magnetic field strength. J Cereb Blood Flow Metab. 2016;36:370-374.
Roach BA, Donahue MJ, Davis LT, et al. Interrogating the functional correlates of collateralization in patients with intracranial stenosis using multimodal hemodynamic imaging. Am J Neuroradiol. 2016;37:1132-1138.
Zaharchuk G, Do HM, Marks MP, Rosenberg J, Moseley ME, Steinberg GK. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke. 2011;42:2485-2491.
Pinter NK, Fritz JV. Neuroimaging for the neurologist: clinical MRI and future trends. Neurol Clin. 2020;38:1-35.
Fan AP, Guo J, Khalighi MM, et al. Long-delay arterial spin labeling provides more accurate cerebral blood flow measurements in Moyamoya patients: a simultaneous positron emission tomography/MRI study. Stroke. 2017;48:2441-2449.
Lou X, Ma X, Liebeskind DS, et al. Collateral perfusion using arterial spin labeling in symptomatic versus asymptomatic middle cerebral artery stenosis. J Cereb Blood Flow Metab. 2019;39:108-117.
Lyu J, Ma N, Liebeskind DS, et al. Arterial spin labeling magnetic resonance imaging estimation of Antegrade and collateral flow in unilateral middle cerebral artery stenosis. Stroke. 2016;47:428-433.
Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magn Reson Med. 1998;40:383-396.
Wang DJJ, Alger JR, Qiao JX, et al. Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage Clin. 2013;3:1-7.
Bokkers RPH, Hernandez DA, Merino JG, et al. Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke. Stroke. 2012;43:1290-1294.
Zaharchuk G, El Mogy IS, Fischbein NJ, Albers GW. Comparison of arterial spin labeling and bolus perfusion-weighted imaging for detecting mismatch in acute stroke. Stroke. 2012;43:1843-1848.
Wang DJJ, Alger JR, Qiao JX, et al. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke. 2012;43:1018-1024.
Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378:11-21.
Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378:708-718.
de Havenon A, Haynor DR, Tirschwell DL, et al. Association of Collateral Blood Vessels Detected by arterial spin labeling magnetic resonance imaging with neurological outcome after ischemic stroke. JAMA Neurol. 2017;74:453-458.
De Vis JB, Alderliesten T, Hendrikse J, Petersen ET, Benders MJNL. Magnetic resonance imaging based noninvasive measurements of brain hemodynamics in neonates: a review. Pediatr Res. 2016;80:641-650.
Le TT, Fischbein NJ, Andre JB, Wijman C, Rosenberg J, Zaharchuk G. Identification of venous signal on arterial spin labeling improves diagnosis of dural arteriovenous fistulas and small arteriovenous malformations. Am J Neuroradiol. 2012;33:61-68.
Togao O, Hiwatashi A, Obara M, et al. Acceleration-selective arterial spin-labeling MR angiography used to visualize distal cerebral arteries and collateral vessels in Moyamoya disease. Radiology. 2018;286:611-621.
Morofuji Y, Horie N, Tateishi Y, et al. Arterial spin labeling magnetic resonance imaging can identify the occlusion site and collateral perfusion in patients with acute ischemic stroke: comparison with digital subtraction angiography. Cerebrovasc Dis. 2019;48:70-76.
Bivard A, Krishnamurthy V, Stanwell P, et al. Arterial spin labeling versus bolus-tracking perfusion in hyperacute stroke. Stroke. 2014;45:127-133.
Yu S, Liebeskind DS, Dua S, et al. Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke. J Cereb Blood Flow Metab. 2015;35:630-637.
Okazaki S, Yamagami H, Yoshimoto T, et al. Cerebral hyperperfusion on arterial spin labeling MRI after reperfusion therapy is related to hemorrhagic transformation. J Cereb Blood Flow Metab. 2017;37:3087-3090.
Lee S, Park DW, Kim TY, et al. A novel visual ranking system based on arterial spin labeling perfusion imaging for evaluating perfusion disturbance in patients with ischemic stroke. PLoS One. 2020;15:e0227747.
Bolar DS, Gagoski B, Orbach DB, et al. Comparison of CBF measured with combined velocity-selective arterial spin-labeling and pulsed arterial spin-labeling to blood flow patterns assessed by conventional angiography in pediatric Moyamoya. Am J Neuroradiol. 2019;40:1842-1849.
Qiu D, Straka M, Zun Z, Bammer R, Moseley ME, Zaharchuk G. CBF measurements using multidelay pseudocontinuous and velocity-selective arterial spin labeling in patients with long arterial transit delays: comparison with xenon CT CBF. J Magn Reson Imaging. 2012;36:110-119.
Di Napoli A, Cheng SF, Gregson J, et al. Arterial spin labeling MRI in carotid stenosis: arterial transit artifacts may predict symptoms. Radiology. 2020;297:652-660.
Donahue MJ, Dethrage LM, Faraco CC, et al. Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis. Stroke. 2014;45:2335-2341.
Hodel J, Leclerc X, Kalsoum E, et al. Intracranial arteriovenous shunting: detection with arterial spin-labeling and susceptibility-weighted imaging combined. AJNR Am J Neuroradiol. 2017;38:71-76.
Wolf RL, Wang J, Detre JA, Zager EL, Hurst RW. Arteriovenous shunt visualization in arteriovenous malformations with arterial spin-labeling MR imaging. AJNR Am J Neuroradiol. 2008;29:681-687.
Heit JJ, Thakur NH, Iv M, et al. Arterial-spin labeling MRI identifies residual cerebral arteriovenous malformation following stereotactic radiosurgery treatment. J Neuroradiol. 2020;47:13-19.
Sunwoo L, Sohn C-H, Lee JY, et al. Evaluation of the degree of arteriovenous shunting in intracranial arteriovenous malformations using pseudo-continuous arterial spin labeling magnetic resonance imaging. Neuroradiology. 2015;57:775-782.
Amponsah K, Ellis TL, Chan MD, et al. Retrospective analysis of imaging techniques for treatment planning and monitoring of obliteration for gamma knife treatment of cerebral arteriovenous malformation. Neurosurgery. 2012;71:893-899.
Suazo L, Foerster B, Fermin R, et al. Measurement of blood flow in arteriovenous malformations before and after embolization using arterial spin labeling. Interv Neuroradiol. 2012;18:42-48.
Blauwblomme T, Naggara O, Brunelle F, et al. Arterial spin labeling magnetic resonance imaging: toward noninvasive diagnosis and follow-up of pediatric brain arteriovenous malformations. J Neurosurg Pediatr. 2015;15:451-458.
Pollock JM, Whitlow CT, Simonds J, et al. Response of arteriovenous malformations to gamma knife therapy evaluated with pulsed arterial spin-labeling MRI perfusion. AJR Am J Roentgenol. 2011;196:15-22.
Iv M, Fischbein NJ, Zaharchuk G. Association of developmental venous anomalies with perfusion abnormalities on arterial spin labeling and bolus perfusion-weighted imaging. J Neuroimaging. 2015;25:243-250.
Juttukonda MR, Donahue MJ, Davis LT, et al. Preliminary evidence for cerebral capillary shunting in adults with sickle cell anemia. J Cereb Blood Flow Metab. 2019;39:1099-1110. doi:10.1177/0271678x17746808
Bush A, Chai Y, Choi SY, et al. Pseudo continuous arterial spin labeling quantification in anemic subjects with hyperemic cerebral blood flow. Magn Reson Imaging. 2018;47:137-146.
Juttukonda MR, Donahue MJ, Waddle SL, et al. Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting. J Cereb Blood Flow Metab. 2021;41:546-560.
Falk Delgado A, De Luca F, van Westen D, Falk DA. Arterial spin labeling MR imaging for differentiation between high- and low-grade glioma-a meta-analysis. Neuro Oncol. 2018;20:1450-1461.
Dangouloff-Ros V, Deroulers C, Foissac F, et al. Arterial spin labeling to predict brain tumor grading in children: correlations between histopathologic vascular density and perfusion MR imaging. Radiology. 2016;281:553-566.
Smits M. MRI biomarkers in neuro-oncology. Nat Rev Neurol. 2021;17:486-500. doi:10.1038/s41582-021-00510-y
Sunwoo L, Yun TJ, You S-H, et al. Differentiation of glioblastoma from brain metastasis: qualitative and quantitative analysis using arterial spin labeling MR imaging. PLoS One. 2016;11:e0166662.
Weber MA, Zoubaa S, Schlieter M, et al. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006;66:1899-1906.
Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ. Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis. Eur Radiol. 2018;28:3819-3831.
Alsaedi A, Doniselli F, Jäger HR, et al. The value of arterial spin labelling in adults glioma grading: systematic review and meta-analysis. Oncotarget. 2019;10:1589-1601.
Choi YJ, Kim HS, Jahng G-H, Kim SJ, Suh DC. Pseudoprogression in patients with glioblastoma: added value of arterial spin labeling to dynamic susceptibility contrast perfusion MR imaging. Acta Radiol. 2013;54:448-454.
Manning P, Daghighi S, Rajaratnam MK, et al. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma. J Neurooncol. 2020;147:681-690.
Maral H, Ertekin E, Tunçyürek Ö, Özsunar Y. Effects of susceptibility artifacts on perfusion MRI in patients with primary brain tumor: a comparison of arterial spin-labeling versus DSC. AJNR Am J Neuroradiol. 2020;41:255-261.
Yang S, Zhao B, Wang G, et al. Improving the grading accuracy of astrocytic neoplasms noninvasively by combining timing information with cerebral blood flow: a multi-TI arterial spin-labeling MR imaging study. AJNR Am J Neuroradiol. 2016;37:2209-2216.
Crameri F, Shephard GE, Heron PJ. The misuse of colour in science communication. Nat Commun. 2020;11:5444.
Zabala-Travers S, Choi M, Cheng W-C, Badano A. Effect of color visualization and display hardware on the visual assessment of pseudocolor medical images. Med Phys. 2015;42:2942-2954.
Andre JB, Nagpal S, Hippe DS, et al. Cerebral blood flow changes in glioblastoma patients undergoing bevacizumab treatment are seen in both tumor and Normal brain. Neuroradiol J. 2015;28:112-119.
Petr J, Platzek I, Hofheinz F, et al. Photon vs. proton radiochemotherapy, effects on brain tissue volume and perfusion. Radiother Oncol. 2018;In press;128:121-127. doi:10.1016/j.radonc.2017.11.033
Sandson TA, O'Connor M, Sperling RA, Edelman RR, Warach S. Noninvasive perfusion MRI in Alzheimer's disease: a preliminary report. Neurology. 1996;47:1339-1342.
Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol. 2000;47:93-100.
Binnewijzend MAA, Kuijer JPA, Benedictus MR, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology. 2013;267:221-230.
Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005;234:851-859.
Tosun D, Schuff N, Rabinovici GD, et al. Diagnostic utility of ASL-MRI and FDG-PET in the behavioral variant of FTD and AD. Ann Clin Transl Neurol. 2016;3:740-751.
Dai W, Lopez OL, Carmichael OT, Becker JT, Kuller LH, Gach HM. Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging. Radiology. 2009;250:856-866.
Alsop DC, Casement M, De BC, Fong T, Press DZ. Hippocampal hyperperfusion in Alzheimer's disease. Neuroimage. 2008;42:1267-1274.
Hu WT, Wang Z, Lee VM, Hu WT, Lee VM. Distinct cerebral perfusion patterns in FTLD and AD. Neurology. 2011;75:881-888. doi:10.1212/WNL.0b013e3181f11e35
Asllani I, Habeck C, Scarmeas N, Borogovac A, Brown TR, Stern Y. Multivariate and univariate analysis of continuous arterial spin labeling perfusion MRI in Alzheimer's disease. J Cereb Blood Flow Metab. 2008;28:725-736.
Chao LL, Buckley ST, Kornak J, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord. 2010;24:19-27.
Mutsaerts HJMM, Mirza SS, Petr J, et al. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study. Brain. 2019;142:1108-1120.
Dolui S, Li Z, Nasrallah IM, Detre JA, Wolk DA. Arterial spin labeling versus F-FDG-PET to identify mild cognitive impairment. Neuroimage Clin. 2020;25:102146.
Nedelska Z, Senjem ML, Przybelski SA, et al. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: associations with clinical severity, glucose metabolism and tau PET. Neuroimage Clin. 2018;19:939-947.
Kamagata K, Motoi Y, Hori M, et al. Posterior hypoperfusion in Parkinson's disease with and without dementia measured with arterial spin labeling MRI. J Magn Reson Imaging. 2011;33:803-807.
Fällmar D, Haller S, Lilja J, et al. Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET. Eur Radiol. 2017;27:4237-4246.
Steketee RME, Bron EE, Meijboom R, et al. Early-stage differentiation between presenile Alzheimer's disease and frontotemporal dementia using arterial spin labeling MRI. Eur Radiol. 2016;26:244-253.
Du AT, Jahng GH, Hayasaka S, et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology. 2006;67:1215-1220.
Mak E, Dounavi M-E, Low A, et al. Proximity to dementia onset and multi-modal neuroimaging changes: the prevent-dementia study. Neuroimage. 2021;229:117749.
Li D, Liu Y, Zeng X, et al. Quantitative study of the changes in cerebral blood flow and iron deposition during progression of Alzheimer's disease. J Alzheimers Dis. 2020;78:439-452.
Kim SM, Kim MJ, Rhee HY, et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology. 2013;55:25-34.
Xekardaki A, Rodriguez C, Montandon M-L, et al. Arterial spin labeling may contribute to the prediction of cognitive deterioration in healthy elderly individuals. Radiology. 2015;274:490-499.
Brendel M, Barthel H, van Eimeren T, et al. Assessment of 18F-PI-2620 as a biomarker in progressive Supranuclear palsy. JAMA Neurol. 2020;77:1408-1419.
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42:2672-2713.
Simão F, Pagnussat AS, Seo JH, et al. Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab. 2012;32:884-895.
Chappell MA, McConnell FAK, Golay X, et al. Partial volume correction in arterial spin labeling perfusion MRI: a method to disentangle anatomy from physiology or an analysis step too far? Neuroimage. 2021;238:118236.
Petr J, Mutsaerts HJMM, De Vita E, et al. Effects of systematic partial volume errors on the estimation of gray matter cerebral blood flow with arterial spin labeling MRI. MAGMA 2018;31:725-734.
Lee C, Lopez OL, Becker JT, et al. Imaging cerebral blood flow in the cognitively normal aging brain with arterial spin labeling: implications for imaging of neurodegenerative disease. J Neuroimaging. 2009;19:344-352.
Pettigrew C, Soldan A, Zhu Y, et al. Cognitive reserve and rate of change in Alzheimer's and cerebrovascular disease biomarkers among cognitively normal individuals. Neurobiol Aging. 2019;88:33-41. doi:10.1016/j.neurobiolaging.2019.12.003
Plassman BL, Williams JW Jr, Burke JR, Holsinger T, Benjamin S. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 2010;153:182-193.
Lendahl U, Nilsson P, Betsholtz C. Emerging links between cerebrovascular and neurodegenerative diseases-a special role for pericytes. EMBO Rep. 2019;20:e48070.
Dolui S, Tisdall D, Vidorreta M, et al. Characterizing a perfusion-based periventricular small vessel region of interest. Neuroimage Clin. 2019;23:101897.
Van Osch MJP, Teeuwisse WM, Van Walderveen MAA, et al. Can arterial spin labeling detect white matter perfusion signal? Magn Reson Med. 2009;62:165-173.
Skurdal MJ, Bjornerud A, van Osch MJP, Nordhoy W, Lagopoulos J, Groote IR. Voxel-wise perfusion assessment in cerebral white matter with PCASL at 3T; is it possible and how long does it take? PLoSOne. 2015;10:e0135596.
Tortora D, Mattei PA, Navarra R, et al. Prematurity and brain perfusion: arterial spin labeling MRI. Neuroimage Clin. 2017;15:401-407.
Hu HH, Rusin JA, Peng R, et al. Multi-phase 3D arterial spin labeling brain MRI in assessing cerebral blood perfusion and arterial transit times in children at 3T. Clin Imaging. 2019;53:210-220.
Avants BB, Duda JT, Kilroy E, et al. The pediatric template of brain perfusion. Scientific Data. 2015;2:150003.
Carsin-Vu A, Corouge I, Commowick O, et al. Measurement of pediatric regional cerebral blood flow from 6 months to 15 years of age in a clinical population. Eur J Radiol. 2018;101:38-44.
Zun Z, Shankaranarayanan A, Zaharchuk G. Pseudocontinuous arterial spin labeling with prospective motion correction (PCASL-PROMO). Magn Reson Med. 2014;72:1049-1056.
Václavů L, van der Land V, Heijtel DFR, et al. In vivo T1 of blood measurements in children with sickle cell disease improve cerebral blood flow quantification from arterial spin-labeling MRI. AJNR Am J Neuroradiol. 2016;37:1727-1732.
De Vis JB, Hendrikse J, Groenendaal F, et al. Impact of neonate haematocrit variability on the longitudinal relaxation time of blood: implications for arterial spin labelling MRI. Neuroimage Clin. 2014;4:517-525.
Biagi L, Abbruzzese A, Bianchi MC, Alsop DC, Del Guerra A, Tosetti M. Age dependence of cerebral perfusion assessed by magnetic resonance continuous arterial spin labeling. J Magn Reson Imaging. 2007;25:696-702.
Kandel BM, Wang DJJ, Detre JA, Gee JC, Avants BB. Decomposing cerebral blood flow MRI into functional and structural components: a non-local approach based on prediction. Neuroimage. 2015;105:156-170.
Gousias IS, Edwards AD, Rutherford MA, et al. Magnetic resonance imaging of the newborn brain: manual segmentation of labelled atlases in term-born and preterm infants. Neuroimage. 2012;62:1499-1509.
Shi F, Yap P-T, Wu G, et al. Infant brain atlases from neonates to 1- and 2-year-olds. PLoS One. 2011;6:e18746.
NITRC. UNC Human Brain Atlas: Tool/Resource Info. https://www.nitrc.org/projects/unc_brain_atlas/. Accessed May 8, 2021.
Ouyang M, Liu P, Jeon T, et al. Heterogeneous increases of regional cerebral blood flow during preterm brain development: preliminary assessment with pseudo-continuous arterial spin labeled perfusion MRI. Neuroimage. 2017;147:233-242.
Kim HG, Lee JH, Choi JW, Han M, Gho S-M, Moon Y. Multidelay arterial spin-labeling MRI in neonates and infants: cerebral perfusion changes during brain maturation. Am J Neuroradiol. 2018;39:1912-1918.
Proisy M, Bruneau B, Rozel C, et al. Arterial spin labeling in clinical pediatric imaging. Diagn Interv Imaging. 2016;97:151-158.
Morris EA, Juttukonda MR, Lee CA, et al. Elevated brain oxygen extraction fraction in preterm newborns with anemia measured using noninvasive MRI. J Perinatol. 2018;38:1636-1643.
Makki MI, O'Gorman RL, Buhler P, et al. Total cerebrovascular blood flow and whole brain perfusion in children sedated using propofol with or without ketamine at induction: an investigation with 2D-cine PC and ASL. J Magn Reson Imaging. 2019;50:1433-1440.
Leeman-Markowski B. Review of MRI-negative epilepsy. JAMA Neurol. 2016;73:1377.
Gajdoš M, Říha P, Kojan M, et al. Epileptogenic zone detection in MRI negative epilepsy using adaptive thresholding of arterial spin labeling data. Sci Rep. 2021;11:10904.
Pizzini FB, Farace P, Manganotti P, et al. Cerebral perfusion alterations in epileptic patients during peri-ictal and post-ictal phase: PASL vs DSC-MRI. Magn Reson Imaging. 2013;31:1001-1005.
Fallatah SM, Pizzini FB, Gomez-Anson B, et al. A visual quality control scale for clinical arterial spin labeling images. Eur Radiol Exp. 2018;2:45.
Boscolo Galazzo I, Mattoli MV, Pizzini FB, et al. Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling. NeuroImage Clin. 2016;11:648-657.
Chen DY-T, Kuo Y-S, Hsu H-L, et al. Loss of labelling efficiency caused by carotid stent in pseudocontinuous arterial spin labelling perfusion study. Clin Radiol. 2016;71:e21-e27.
Barkeij Wolf JJH, Foster-Dingley JC, Moonen JEF, et al. Unilateral fetal-type circle of Willis anatomy causes right-left asymmetry in cerebral blood flow with pseudo-continuous arterial spin labeling: a limitation of arterial spin labeling-based cerebral blood flow measurements? J Cereb Blood Flow Metab. 2016;36:1570-1578.
Qu Y, Kong D, Wen H, et al. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI. Eur Radiol. 2022;32:2976-2987.

Auteurs

Thomas Lindner (T)

Department of Diagnostic and Interventional Neuroradiology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Divya S Bolar (DS)

Center for Functional Magnetic Resonance Imaging, Department of Radiology, University of California San Diego, San Diego, California, USA.

Eric Achten (E)

Department of Radiology and Nuclear Medicine, Ghent University, Ghent, Belgium.

Frederik Barkhof (F)

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK.

António J Bastos-Leite (AJ)

Faculty of Medicine, University of Porto, Porto, Portugal.

John A Detre (JA)

Department of Neurology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Xavier Golay (X)

UCL Queen Square Institute of Neurology, University College London, London, UK.

Matthias Günther (M)

University of Bremen, Bremen, Germany.
Fraunhofer MEVIS, Bremen, Germany.
Mediri GmbH, Heidelberg, Germany.

Danny J J Wang (DJJ)

Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

Sven Haller (S)

CIMC - Centre d'Imagerie Médicale de Cornavin, Genève, Switzerland.
Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
Faculty of Medicine of the University of Geneva, Geneva, Switzerland.
Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Silvia Ingala (S)

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Hans R Jäger (HR)

UCL Queen Square Institute of Neuroradiology, University College London, London, UK.

Geon-Ho Jahng (GH)

Department of Radiology, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Republic of Korea.

Meher R Juttukonda (MR)

Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
Department of Radiology, Harvard Medical School, Boston, Massachusetts, USA.

Vera C Keil (VC)

Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Hirohiko Kimura (H)

Department of Radiology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

Mai-Lan Ho (ML)

Radiology, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio, USA.

Maarten Lequin (M)

Division Imaging and Oncology, Department of Radiology and Nuclear Medicine, University Medical Center Utrecht and Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.

Xin Lou (X)

Department of Radiology, Chinese PLA General Hospital, Beijing, China.

Jan Petr (J)

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.

Nandor Pinter (N)

Dent Neurologic Institute, Buffalo, New York, USA.
University at Buffalo Neurosurgery, Buffalo, New York, USA.

Francesca B Pizzini (FB)

Radiology Institute, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.

Marion Smits (M)

Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
The Brain Tumour Centre, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

Magdalena Sokolska (M)

Department of Medical Physics and Biomedical Engineering, University College London Hospitals NHS Foundation Trust, London, UK.

Greg Zaharchuk (G)

Stanford University, Stanford, California, USA.

Henk J M M Mutsaerts (HJMM)

Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH